Merck & (MRK) Earnings Analysis
Merck & (MRK) next reports earnings on 2026-10-29, consensus EPS 2.27 USD. Last quarter (2026-04-30) it beat with EPS -1.28 USD vs -1.47 USD est (+12.9%). It has beaten estimates in 4/4 recent quarters (100%). Trailing P/E 35.82.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does MRK next report earnings?
| Next earnings date | 2026-10-29 |
|---|---|
| Consensus EPS estimate | 2.27 USD |
| Revenue estimate | 17.28B |
MRK earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-30 | -1.28 USD | -1.47 USD | +12.9% | Beat |
| 2026-02-03 | 2.04 USD | 2.01 USD | +1.5% | Beat |
| 2025-10-30 | 2.58 USD | 2.36 USD | +9.3% | Beat |
| 2024-10-31 | 1.57 USD | 1.5 USD | +4.7% | Beat |
Beat rate: 4/4 (100%) over reported quarters with consensus data.
MRK valuation and analyst view
| Trailing P/E | 35.82 |
|---|---|
| Trailing EPS | 3.614 USD |
| Price / book | 6.87 |
| Dividend yield | 2.63% |
| Market cap | 315.67B |
| Analyst consensus | Buy (25 buy / 11 hold / 1 sell) |
| Avg price target | 140.71 USD |
Related research pages
Frequently asked questions
When is Merck & (MRK)'s next earnings date?
Merck & is next scheduled to report on 2026-10-29, with a consensus EPS estimate of 2.27 USD and revenue estimate of 17.28B.
Did MRK beat earnings last quarter?
In its 2026-04-30 report, MRK posted EPS of -1.28 USD versus a -1.47 USD estimate — a beat of 12.9%.
What is MRK's earnings track record?
Over the last 4 reported quarters with consensus data, MRK beat estimates 4 times (100%).
What is MRK's current P/E ratio and EPS?
MRK trades at a trailing P/E of 35.82 on trailing EPS of 3.6144602682427087 USD.
What do analysts rate MRK?
Analyst consensus is "Buy" across 37 ratings (0 strong buy, 25 buy, 11 hold, 1 sell, 0 strong sell). Average 12-month price target: 140.71 USD.